Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shinich Katsuki"'
Autor:
Ichiro Takemasa, Hiroyuki Ohnuma, Tetsuji Takayama, Tamotsu Sagawa, Hiroshi Miyamoto, Takayuki Nobuoka, Mitsuo Shimada, Yasuo Takahashi, Koshi Fujikawa, Minoru Takahashi, Shinich Katsuki, Masahiro Hirakawa, Junji Kato, Yutaka Okagawa, Koichi Okamoto, Yasushi Sato, Syouhei Kikuch, Minami Shinya, Uemura Naoki, Masahiro Maeda
Publikováno v:
Gastric Cancer. 20:517-526
Conversion therapy is an option for unresectable metastatic gastric cancer when distant metastases are controlled by chemotherapy; however, the feasibility and efficacy remain unclear. This study aimed to assess the feasibility and efficacy of conver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9be84e0729c5ec678be78ec3ce60444b
https://doi.org/10.1007/s10120-016-0633-1
https://doi.org/10.1007/s10120-016-0633-1
Autor:
Takahiro Osuga, Yasuhiro Sato, Jinsei Miyoshi, Shinich Katsuki, Masahiro Hirakawa, Koichi Hirata, Takayuki Nobuoka, Toshi Takaoka, Rishu Takimoto, Junji Kato, Tomohiro Kubo, Miwako Kagawa, Hiroshi Miyamoto, Tetsuji Takayama, Masayoshi Kobune, Yasuo Takahashi, Toshinori Okuda, Yasushi Sato, Yasuhiro Mitsui, Hiroyuki Ohnuma, Yasuteru Fujino, Tamotsu Sagawa
Publikováno v:
Cancer Chemotherapy and Pharmacology. 76:375-382
We previously reported that a triplet combination of docetaxel, cisplatin, and S-1 (DCS) is active against metastatic gastric cancer with a very high response rate of 87.1 % in a phase II study. Recently, the efficacy of trastuzumab (T-mab) for the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d673770a79bb67868c640f192a53d27d
https://doi.org/10.1007/s00280-015-2807-7
https://doi.org/10.1007/s00280-015-2807-7
Autor:
Hiroshi Miyamoto, Keisuke Harada, Minoru Takahashi, Tetsuji Takayama, Yasuhiro Sato, Takayuki Nobuoka, Shinich Katsuki, Masahiro Hirakawa, Koji Miyanishi, Koichi Hirata, Hiroyuki Ohnuma, Tamotsu Sagawa, Michihiro Ono, Tsuyoshi Hayashi, Rishu Takimoto, Tsutomu Sato, Yasushi Sato, Junji Kato, Masahiro Maeda, Michiaki Hirayama, Kohichi Takada, Masayoshi Kobune, Yasuo Takahashi
Publikováno v:
Cancer Chemotherapy and Pharmacology. 71:789-797
The combination of docetaxel, cisplatin, and S-1 (DCS) chemotherapy is expected to be a promising regimen for advanced gastric cancer. This study was performed to evaluate the efficacy and safety of neoadjuvant DCS chemotherapy for locally advanced r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::980603d9f4e79b43e3a5ff1fa5fee837
https://doi.org/10.1007/s00280-013-2073-5
https://doi.org/10.1007/s00280-013-2073-5
Autor:
Yasushi Sato, Hiroyuki Ohnuma, Takayuki Nobuoka, Masahiro Hirakawa, Tamotsu Sagawa, Koshi Fujikawa, Yasuo Takahashi, Minami Shinya, Shinich Katsuki, Minoru Takahashi, Masahiro Maeda, Yutaka Okagawa, Uemura Naoki, Syouhei Kikuch, Koichi Okamoto, Hiroshi Miyamoto, Mitsuo Shimada, Ichiro Takemasa, Junji Kato, Tetsuji Takayama
Publikováno v:
Gastric Cancer. 20:527-527
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9acf2a8c34064e17fa09c74b38bcf253
https://doi.org/10.1007/s10120-016-0643-z
https://doi.org/10.1007/s10120-016-0643-z
Autor:
K. Murase, Junji Kato, Masayoshi Kobune, Tetsuji Takayama, Michiaki Hirayama, Y. Takahashi, Shinich Katsuki, Masahiro Hirakawa, K. Takada, T. Sagawa, Takahiro Osuga, Hiroyuki Ohnuma, Yasushi Sato, R. Takimoto, Shohei Kikuchi, Makoto Takahashi, Y. Okagawa, K. Miyanishi, Tsutomu Sato, M. Maeda
Publikováno v:
European Journal of Cancer. 51:S431
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a475160054d7781ec808ef5b747fd39f
https://doi.org/10.1016/s0959-8049(16)31214-x
https://doi.org/10.1016/s0959-8049(16)31214-x
Autor:
Yasushi Sato, Shinich Katsuki, Masahiro Hirakawa, Tokunori Okuda, Tamotsu Sagawa, Tsuyoshi Hayashi, Koji Miyanishi, Kohichi Takada, Hiroyuki Ohnuma, Rishu Takimoto, Takahiro Osuga, Yasuo Takahashi, Takayuki Nobuoka, Tetsuji Takayama, Koichi Hirata, Junji Kato, Tsutomu Sato, Yasuhiro Sato, Masayoshi Kobune, Hiroshi Miyamoto
Publikováno v:
Journal of Clinical Oncology. 32:124-124
124 Background: Recently the efficacy of trastuzumab (T-mab) for HER2-positive gastric cancer has been reported. We have developed a triplet-drug combination regimen consisting of docetaxel, CDDP, and S-1 (DCS) and reported that the regimen provides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9215c81f44921fa0755c81421c4b4f51
https://doi.org/10.1200/jco.2014.32.3_suppl.124
https://doi.org/10.1200/jco.2014.32.3_suppl.124